Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Carlsbad, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Lineage Cell Therapeutics, Inc. has filed 1,802 SEC EDGAR filings since 17 Apr 1996

SEC filing history

Showing 76-100 of 1,000 matching filings.

Per page
25
Current page
4
PRE 14A File 001-12830

PRE 14A

Filing date
29 Nov 2024
Reporting date
29 Nov 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
26 Nov 2024
Reporting date
26 Nov 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
26 Nov 2024
Reporting date
26 Nov 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
25 Nov 2024
Reporting date
22 Nov 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
22 Nov 2024
Reporting date
21 Nov 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-42290

SC 13D/A filing

Filing date
21 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-277758

424B5

Filing date
21 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-42290

SC 13G filing

Filing date
08 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-42290

SC 13G filing

Filing date
22 Oct 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
19 Aug 2024
Reporting date
16 Aug 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
03 Jul 2024
Reporting date
01 Jul 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
03 Jul 2024
Reporting date
01 Jul 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
03 Jul 2024
Reporting date
01 Jul 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
03 Jul 2024
Reporting date
01 Jul 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
03 Jul 2024
Reporting date
01 Jul 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
03 Jul 2024
Reporting date
01 Jul 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
03 Jul 2024
Reporting date
01 Jul 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
28 May 2024
Reporting date
24 May 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .